Inhibition of Macrophage Oxidative Stress Prevents the Reduction of ABCA-1 Transporter Induced by Advanced Glycated Albumin


Autoria(s): Pinto, Raphael de Souza; Castilho, Gabriela; Paim, Bruno Alves; Machado-Lima, Adriana; Inada, Natalia Mayumi; Nakandakare, Edna Regina; Vercesi, Anibal Eugenio; Passarelli, Marisa
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

30/10/2013

30/10/2013

2012

Resumo

We investigated the role of aminoguanidine and benfotiamine on the inhibition of reactive oxygen species (ROS) generation in macrophages induced by advanced glycated albumin (AGE-albumin) and its relationship with cell cholesterol homeostasis, emphasizing the expression of the ATP binding cassette transporter A-1 (ABCA-1). AGE-albumin was made by incubating fatty acid-free albumin with 10 mM glycolaldehyde. ROS production and ABCA-1 protein level were determined by flow cytometry in J774 macrophages treated along time with control (C) or AGE-albumin alone or in the presence of aminoguanidine or benfotiamine. Mitochondrial function was evaluated by oxygraphy. Compared to C-albumin, AGE-albumin increased ROS production in macrophages, which was ascribed to the activities of NADPH oxidase and of the mitochondrial system. Mitochondrial respiratory chain activity was reduced in cells incubated with AGE-albumin. ROS generation along time was associated with the reduction in macrophage ABCA-1 protein level. Aminoguanidine prevented ROS elevation and restored the ABCA-1 content in macrophages; on the other hand, benfotiamine that promoted a lesser reduction in ROS generation was not able to restore ABCA-1 levels. Inhibition of oxidative stress induced by AGE-albumin prevents disturbances in reverse cholesterol transport by curbing the reduction of ABCA-1 elicited by advanced glycation in macrophages and therefore may contribute to the prevention of atherosclerosis in diabetes mellitus.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

FAPESP, Brazil

FAPESP (Brazil)

Identificador

LIPIDS, HEIDELBERG, v. 47, n. 5, supl. 1, Part 3, pp. 443-450, MAY, 2012

0024-4201

http://www.producao.usp.br/handle/BDPI/36893

10.1007/s11745-011-3647-9

http://dx.doi.org/10.1007/s11745-011-3647-9

Idioma(s)

eng

Publicador

SPRINGER HEIDELBERG

HEIDELBERG

Relação

LIPIDS

Direitos

closedAccess

Copyright SPRINGER HEIDELBERG

Palavras-Chave #ADVANCED GLYCATION END PRODUCTS #CHOLESTEROL EFFLUX #ABCA-1 #OXIDATIVE STRESS #AMINOGUANIDINE #BENFOTIAMINE #END-PRODUCTS #DIABETIC COMPLICATIONS #HYPERGLYCEMIC DAMAGE #CHOLESTEROL EFFLUX #MAILLARD REACTION #GENE-EXPRESSION #PATHWAYS #RECEPTORS #MECHANISM #CELLS #BIOCHEMISTRY & MOLECULAR BIOLOGY #NUTRITION & DIETETICS
Tipo

article

original article

publishedVersion